Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Loss of CCAAT/enhancer binding protein δ promotes chromosomal instability

Oncogene volume 23, pages 1549–1557 (2004)Cite this article

Abstract

The transcription factor CCAAT/enhancer binding protein δ (Cebpd, also known as C/EBPδ, CRP3, CELF, NF-IL6β) is implicated in diverse cellular functions such as the acute phase response, adipocyte differentiation, learning and memory, and mammary epithelial cell growth control. Here, we report that lack of Cebpd causes genomic instability and centrosome amplifications in primary embryonic fibroblasts derived from 129S1 mice. Upon spontaneous immortalization, Cebpd-deficient fibroblasts acquire transformed features such as impaired contact inhibition and reduced serum dependence. These data identify a novel role for Cebpd in the maintenance of chromosomal stability and suggest a potential tumor suppressor function in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Barone MV, Crozat A, Tabaee A, Philipson L and Ron D . (1994). Genes Dev., 8, 453–464.

  • Billiard J, Grewal SS, Lukaesko L, Stork PJ and Rotwein P . (2001). J. Biol. Chem., 276, 31238–31246.

  • Breed DR, Margraf LR, Alcorn JL and Mendelson CR . (1997). Endocrinology, 138, 5527–5534.

  • Cassel TN, Nordlund-Moller L, Andersson O, Gustafsson JA and Nord M . (2000). Am. J. Respir. Cell Mol. Biol., 22, 469–480.

  • Charles A, Tang X, Crouch E, Brody JS and Xiao ZX . (2001). J. Cell. Biochem., 83, 414–425.

  • Chen PL, Riley DJ, Chen Y and Lee WH . (1996a). Genes Dev., 10, 2794–2804.

  • Chen PL, Riley DJ, Chen-Kiang S and Lee WH . (1996b). Proc. Natl. Acad. Sci. USA, 93, 465–469.

  • Chinery R, Brockman JA, Dransfield DT and Coffey RJ . (1997). J. Biol. Chem., 272, 30356–30361.

  • Choy L and Derynck R . (2003). J. Biol. Chem., 278, 9609–9619.

  • Davisson MT . (1994). Gene, 147, 157–160.

  • Del Sal G, Ruaro ME, Philipson L and Schneider C . (1992). Cell, 70, 595–607.

  • Deng C, Zhang P, Harper JW, Elledge SJ and Leder P . (1995). Cell, 82, 675–684.

  • Doxsey S . (2001). Nat. Rev. Mol. Cell Biol., 2, 688–698.

  • Duensing S and Munger K . (2001). Biochim. Biophys. Acta, 1471, M81–8.

  • Evdokiou A and Cowled PA . (1998). Int. J. Cancer, 75, 568–577.

  • Fornace Jr AJ, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J and Holbrook NJ . (1989). Mol. Cell. Biol., 9, 4196–4203.

  • Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF . (1996). Science, 271, 1744–1747.

  • Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G and Ried T . (2000). Genes Chromosomes Cancer, 27, 183–190.

  • Gigliotti AP and DeWille JW . (1998). J. Cell. Physiol., 174, 232–239.

  • Gigliotti AP and DeWille JW . (1999). Breast Cancer Res. Treat., 58, 57–63.

  • Gigliotti AP, Johnson PF, Sterneck E and DeWille JW . (2003). Exp. Biol. Med. (Maywood), 228, 278–285.

  • Glick A, Popescu N, Alexander V, Ueno H, Bottinger E and Yuspa SH . (1999). Proc. Natl. Acad. Sci. USA, 96, 14949–14954.

  • Hoeijmakers JH . (2001). Nature, 411, 366–374.

  • Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM and Pledger WJ . (2002). Oncogene, 21, 8486–8497.

  • Jainchill JL, Aaronson SA and Todaro GJ . (1969). J. Virol., 4, 549–553.

  • Janssen RA and Mier JW . (1997). Mol. Biol. Cell, 8, 897–908.

  • Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR and Tenen DG . (2001). Mol. Cell. Biol., 21, 3789–3806.

  • Kreidberg JA and Natoli TA . (2001). Tumor Suppressor Genes in Human Cancer, Fisher DE (ed). Humana Press Inc.: Totowa, NH, pp. 3–28.

    Google Scholar 

  • Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, Barlow C, Wynshaw-Boris A, Janz S, Wienberg J, Ferguson-Smith MA, Schrock E and Ried T . (1996). Nat. Genet., 14, 312–315.

  • Montagna C, Andrechek ER, Padilla-Nash H, Muller WJ and Ried T . (2002). Oncogene, 21, 890–898.

  • O'Rourke JP, Newbound GC, Hutt JA and DeWille J . (1999). J. Biol. Chem., 274, 16582–16589.

  • Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W and Tenen DG . (2001). Nat. Genet., 27, 263–270.

  • Palmero I, McConnell B, Parry D, Brookes S, Hara E, Bates S, Jat P and Peters G . (1997). Oncogene, 15, 495–503.

  • Pantoja C and Serrano M . (1999). Oncogene, 18, 4974–4982.

  • Piek E and Roberts AB . (2001). Adv. Cancer Res., 83, 1–54.

  • Ramji DP and Foka P . (2002). Biochem. J., 365, 561–575.

  • Reitmair AH, Risley R, Bristow RG, Wilson T, Ganesh A, Jang A, Peacock J, Benchimol S, Hill RP, Mak TW, Fishel R and Meuth M . (1997). Cancer Res., 57, 3765–3771.

  • Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA and Dynlacht BD . (2002). Genes Dev., 16, 245–256.

  • Salisbury JL, Whitehead CM, Lingle WL and Barrett SL . (1999). Biol. Cell, 91, 451–460.

  • Sibilia M and Wagner EF . (1995). Science, 269, 234–238.

  • Slomiany BA, D'Arigo KL, Kelly MM and Kurtz DT . (2000). Mol. Cell. Biol., 20, 5986–5997.

  • Sterneck E, Paylor R, Jackson-Lewis V, Libbey M, Przedborski S, Tessarollo L, Crawley JN and Johnson PF . (1998). Proc. Natl. Acad. Sci. USA, 95, 10908–10913.

  • Sterneck E, Tessarollo L and Johnson PF . (1997). Genes Dev., 11, 2153–2162.

  • Sugahara K, Sadohara T, Sugita M, Iyama K and Takiguchi M . (1999). Cell Tissue Res., 297, 261–270.

  • Takiguchi M . (1998). Int. J. Exp. Pathol., 79, 369–391.

  • Tanaka T, Yoshida N, Kishimoto T and Akira S . (1997). EMBO J., 16, 7432–7443.

  • Tang QQ and Lane MD . (1999). Genes Dev., 13, 2231–2241.

  • Tessarollo L . (2001). Methods Mol. Biol., 158, 47–63.

  • Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard YA, Yuspa SH, Coffey RY and Magnuson T . (1995). Science, 269, 230–234.

  • Timchenko NA, Wilde M, Iakova P, Albrecht JH and Darlington GJ . (1999). Nucleic Acids Res., 27, 3621–3630.

  • Timchenko NA, Wilde M, Nakanishi M, Smith JR and Darlington GJ . (1996). Genes Dev., 10, 804–815.

  • Todaro G and Green H . (1963). J. Cell Biol., 17, 299–313.

  • Umayahara Y, Ji C, Centrella M, Rotwein P and McCarthy TL . (1997). J. Biol. Chem., 272, 31793–31800.

  • Wang H, Goode T, Iakova P, Albrecht JH and Timchenko NA . (2002). EMBO J., 21, 930–941.

  • Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ and Timchenko NA . (2001). Mol. Cell, 8, 817–828.

  • Welm AL, Timchenko NA, Ono Y, Sorimachi H, Radomska HS, Tenen DG, Lekstrom-Himes J and Darlington GJ . (2002). J. Biol. Chem., 277, 33848–33856.

  • Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T and Deng CX . (1999). Mol. Cell, 3, 389–395.

  • Zahnow CA, Cardiff RD, Laucirica R, Medina D and Rosen JM . (2001). Cancer Res., 61, 261–269.

  • Zhang S, Ramsay ES and Mock BA . (1998). Proc. Natl. Acad. Sci. USA, 95, 2429–2434.

  • Zhang SL, DuBois W, Ramsay ES, Bliskovski V, Morse III HC, Taddesse-Heath L, Vass WC, DePinho RA and Mock BA . (2001). Mol. Cell. Biol., 21, 310–318.

  • Zhu S, Yoon K, Sterneck E, Johnson PF and Smart RC . (2002). Proc. Natl. Acad. Sci. USA, 99, 207–212.

  • Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL and Ron D . (1998). Genes Dev., 12, 982–995.

Download references

Acknowledgements

We thank Mary Beth Hilton, Barbara Shankle and Lori Warg for expert technical assistance, and Danny Wangsa for help with mouse SKY kits preparation. We thank David Ron, J.L. Salisbury, Claudio Schneider, Richard Janssen and Debbie Morrison for valuable reagents and advice; Karen Vousden's laboratory for generous support with resources and expert advice; Karen Vousden, Shyam Sharan and Lino Tessarollo for critical reading of the manuscript.

Author information

Author notes

  1. Yajun Ni

    Present address: Purdue Pharma LP, One Stamford Forum, Stamford, CT, 06910, USA

Authors and Affiliations

  1. Regulation of Cell Growth Laboratory, PO Box B, Frederick, 21702, MD, USA

    A-Mei Huang, Shikha Sharan, Yajun Ni & Esta Sterneck

  2. Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, 50 South Drive, Bethesda, 20892, MD, USA

    Cristina Montagna & Thomas Ried

Authors
  1. A-Mei Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristina Montagna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shikha Sharan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yajun Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas Ried
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Esta Sterneck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esta Sterneck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, AM., Montagna, C., Sharan, S. et al. Loss of CCAAT/enhancer binding protein δ promotes chromosomal instability. Oncogene 23, 1549–1557 (2004). https://doi.org/10.1038/sj.onc.1207285

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207285

Keywords

This article is cited by

Search

Advanced search

Quick links